Xiao, Yu-Lan http://orcid.org/0000-0003-1498-0890
Liu, Shun
Ge, Ruiqi http://orcid.org/0000-0002-8529-3070
Wu, Yuan
He, Chuan http://orcid.org/0000-0003-4319-7424
Chen, Mengjie http://orcid.org/0000-0003-1579-087X
Tang, Weixin http://orcid.org/0000-0002-5739-5416
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RM1 HG008935 (pilot), RM1 HG008935, R01 HG011883)
National Science Foundation (NSF 2016307)
Alfred P. Sloan Foundation
Article History
Received: 28 April 2022
Accepted: 24 October 2022
First Online: 2 January 2023
Competing interests
: Patent application no. 63/417,245 has been filed for eTAM-seq by the University of Chicago. C.H. is a scientific founder and a scientific advisory board member of Accent Therapeutics, Inc. and Aferna Bio, Inc. The remaining authors declare no competing interests.